Recruitment

Recruitment Status
Unknown status

Inclusion Criterias

Enough relative residual liver volume (%RLV) ≥ 40%.
Clinical diagnosis of resectable HCC.
Written consent inform assigned.
...
Enough relative residual liver volume (%RLV) ≥ 40%.
Clinical diagnosis of resectable HCC.
Written consent inform assigned.
Acceptable clotting profile :platelet count > 50 x 109/L and a prolonged prothrombin time of < 5 seconds.
Indocyanine green retention at 15 minutes (ICG-15) of <30%.
Preoperative liver function test showed Child-Pugh Class A or B.
Aged from 18 to 65 years , no gender restriction.
No metastasis in lymphnode or other organs.
No other anti-tumor therapy received before the treatment.
No tumor invasion in primary branch of portal vein, hepatic vein, or inferior vena cava.

Exclusion Criterias

Pregnancy.
Intraoperative findings of tumor rupture,extrahepatic tumor or lymphnode metastasis.
Tumor invasion in primary branch of portal vein, hepatic vein, or inferior vena cava.
Pregnancy.
Intraoperative findings of tumor rupture,extrahepatic tumor or lymphnode metastasis.
Tumor invasion in primary branch of portal vein, hepatic vein, or inferior vena cava.

Summary

Conditions
  • Cirrhosis
  • Hepatocellular Carcinoma
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Double (Participant, Outcomes Assessor)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 65 years
Gender
Both males and females

Inclusion Criterias

Enough relative residual liver volume (%RLV) ≥ 40%.
Clinical diagnosis of resectable HCC.
Written consent inform assigned.
...
Enough relative residual liver volume (%RLV) ≥ 40%.
Clinical diagnosis of resectable HCC.
Written consent inform assigned.
Acceptable clotting profile :platelet count > 50 x 109/L and a prolonged prothrombin time of < 5 seconds.
Indocyanine green retention at 15 minutes (ICG-15) of <30%.
Preoperative liver function test showed Child-Pugh Class A or B.
Aged from 18 to 65 years , no gender restriction.
No metastasis in lymphnode or other organs.
No other anti-tumor therapy received before the treatment.
No tumor invasion in primary branch of portal vein, hepatic vein, or inferior vena cava.

Exclusion Criterias

Pregnancy.
Intraoperative findings of tumor rupture,extrahepatic tumor or lymphnode metastasis.
Tumor invasion in primary branch of portal vein, hepatic vein, or inferior vena cava.
Pregnancy.
Intraoperative findings of tumor rupture,extrahepatic tumor or lymphnode metastasis.
Tumor invasion in primary branch of portal vein, hepatic vein, or inferior vena cava.

Locations

Chongqing, Chongqing, 400038
Chongqing, Chongqing, 400038

Tracking Information

NCT #
NCT01992978
Collaborators
Not Provided
Investigators
Study Director: Xiaowu Li, MD-Ph D Institute of hepatobiliry surgery,Southwest hospital